Annual SG&A
$4.66 M
-$1.64 M-26.06%
31 December 2023
Summary:
XBiotech annual selling, general & administrative expenses is currently $4.66 million, with the most recent change of -$1.64 million (-26.06%) on 31 December 2023. During the last 3 years, it has fallen by -$13.54 million (-74.38%). XBIT annual SG&A is now -74.38% below its all-time high of $18.20 million, reached on 31 December 2020.XBIT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$777.00 K
-$1.21 M-60.80%
30 September 2024
Summary:
XBiotech quarterly selling, general & administrative expenses is currently $777.00 thousand, with the most recent change of -$1.21 million (-60.80%) on 30 September 2024. Over the past year, it has dropped by -$196.00 thousand (-20.14%). XBIT quarterly SG&A is now -87.56% below its all-time high of $6.25 million, reached on 30 June 2020.XBIT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$270.26 M
-$32.66 M-13.75%
30 September 2024
Summary:
XBiotech TTM selling, general & administrative expenses is currently -$270.26 million, with the most recent change of -$32.66 million (-13.75%) on 30 September 2024. Over the past year, it has dropped by -$275.27 million (-5495.43%). XBIT TTM SG&A is now -137.16% below its all-time high of $18.20 million, reached on 31 December 2020.XBIT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIT Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.1% | -20.1% | -5495.4% |
| 3 y3 years | -74.4% | -49.6% | -2351.4% |
| 5 y5 years | -11.5% | -50.8% | -5073.4% |
XBIT Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -74.4% | at low | -74.3% | at low | -191.9% | at low |
| 5 y | 5 years | -74.4% | at low | -87.6% | at low | -137.2% | +72.6% |
| alltime | all time | -74.4% | +154.9% | -87.6% | +379.6% | -137.2% | +72.6% |
XBiotech Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $777.00 K(-60.8%) | $4.57 M(-4.1%) |
| June 2024 | - | $1.98 M(+92.8%) | $4.77 M(-0.2%) |
| Mar 2024 | - | $1.03 M(+31.3%) | $4.78 M(+2.4%) |
| Dec 2023 | $4.66 M(-26.1%) | $783.00 K(-19.5%) | $4.66 M(-6.9%) |
| Sept 2023 | - | $973.00 K(-51.2%) | $5.01 M(+2.7%) |
| June 2023 | - | $1.99 M(+117.7%) | $4.88 M(-17.5%) |
| Mar 2023 | - | $915.00 K(-19.0%) | $5.91 M(-6.3%) |
| Dec 2022 | $6.30 M(-32.8%) | $1.13 M(+34.4%) | $6.31 M(-10.5%) |
| Sept 2022 | - | $840.00 K(-72.2%) | $7.04 M(-9.1%) |
| June 2022 | - | $3.02 M(+130.1%) | $7.74 M(-16.2%) |
| Mar 2022 | - | $1.31 M(-29.6%) | $9.24 M(-1.6%) |
| Dec 2021 | $9.39 M(-48.4%) | $1.87 M(+21.1%) | $9.39 M(-21.8%) |
| Sept 2021 | - | $1.54 M(-65.9%) | $12.00 M(-13.7%) |
| June 2021 | - | $4.52 M(+208.3%) | $13.91 M(-11.1%) |
| Mar 2021 | - | $1.47 M(-67.3%) | $15.64 M(-14.1%) |
| Dec 2020 | $18.20 M(+154.8%) | $4.48 M(+30.0%) | $18.20 M(+9.0%) |
| Sept 2020 | - | $3.45 M(-44.8%) | $16.69 M(+12.6%) |
| June 2020 | - | $6.25 M(+55.3%) | $14.82 M(+49.9%) |
| Mar 2020 | - | $4.02 M(+35.3%) | $9.89 M(+38.4%) |
| Dec 2019 | $7.14 M | $2.97 M(+88.5%) | $7.14 M(+31.5%) |
| Sept 2019 | - | $1.58 M(+20.2%) | $5.43 M(+8.0%) |
| June 2019 | - | $1.31 M(+2.7%) | $5.03 M(-6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $1.28 M(+1.0%) | $5.39 M(+2.3%) |
| Dec 2018 | $5.27 M(-31.0%) | $1.26 M(+7.7%) | $5.27 M(-6.0%) |
| Sept 2018 | - | $1.18 M(-29.7%) | $5.60 M(-8.0%) |
| June 2018 | - | $1.67 M(+44.5%) | $6.09 M(-9.2%) |
| Mar 2018 | - | $1.16 M(-27.7%) | $6.71 M(-12.1%) |
| Dec 2017 | $7.63 M(-25.7%) | $1.60 M(-3.8%) | $7.63 M(-13.1%) |
| Sept 2017 | - | $1.66 M(-27.3%) | $8.79 M(-10.4%) |
| June 2017 | - | $2.29 M(+9.9%) | $9.81 M(-1.1%) |
| Mar 2017 | - | $2.08 M(-24.4%) | $9.92 M(-3.4%) |
| Dec 2016 | $10.28 M(+65.8%) | $2.76 M(+2.6%) | $10.28 M(+12.0%) |
| Sept 2016 | - | $2.69 M(+11.9%) | $9.18 M(+21.1%) |
| June 2016 | - | $2.40 M(-1.5%) | $7.58 M(+5.0%) |
| Mar 2016 | - | $2.44 M(+46.9%) | $7.22 M(+16.4%) |
| Dec 2015 | $6.20 M(-16.8%) | $1.66 M(+53.1%) | $6.20 M(-5.2%) |
| Sept 2015 | - | $1.08 M(-46.9%) | $6.54 M(-19.2%) |
| June 2015 | - | $2.04 M(+43.5%) | $8.10 M(+20.5%) |
| Mar 2015 | - | $1.42 M(-28.8%) | $6.72 M(-9.8%) |
| Dec 2014 | $7.45 M(+274.3%) | $2.00 M(-24.3%) | $7.45 M(+32.7%) |
| Sept 2014 | - | $2.64 M(+300.5%) | $5.61 M(+88.7%) |
| June 2014 | - | $659.00 K(-69.4%) | $2.98 M(+28.5%) |
| Mar 2014 | - | $2.15 M(+1229.6%) | $2.32 M(+1329.6%) |
| Dec 2013 | $1.99 M(+8.8%) | $162.00 K | $162.00 K |
| Dec 2012 | $1.83 M | - | - |
FAQ
- What is XBiotech annual selling, general & administrative expenses?
- What is the all time high annual SG&A for XBiotech?
- What is XBiotech annual SG&A year-on-year change?
- What is XBiotech quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for XBiotech?
- What is XBiotech quarterly SG&A year-on-year change?
- What is XBiotech TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for XBiotech?
- What is XBiotech TTM SG&A year-on-year change?
What is XBiotech annual selling, general & administrative expenses?
The current annual SG&A of XBIT is $4.66 M
What is the all time high annual SG&A for XBiotech?
XBiotech all-time high annual selling, general & administrative expenses is $18.20 M
What is XBiotech annual SG&A year-on-year change?
Over the past year, XBIT annual selling, general & administrative expenses has changed by -$1.64 M (-26.06%)
What is XBiotech quarterly selling, general & administrative expenses?
The current quarterly SG&A of XBIT is $777.00 K
What is the all time high quarterly SG&A for XBiotech?
XBiotech all-time high quarterly selling, general & administrative expenses is $6.25 M
What is XBiotech quarterly SG&A year-on-year change?
Over the past year, XBIT quarterly selling, general & administrative expenses has changed by -$196.00 K (-20.14%)
What is XBiotech TTM selling, general & administrative expenses?
The current TTM SG&A of XBIT is -$270.26 M
What is the all time high TTM SG&A for XBiotech?
XBiotech all-time high TTM selling, general & administrative expenses is $18.20 M
What is XBiotech TTM SG&A year-on-year change?
Over the past year, XBIT TTM selling, general & administrative expenses has changed by -$275.27 M (-5495.43%)